Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlucoTab basal insulin algorithm versus standard care in geriatric inpatients with type 2 diabetes
2017-000955-25Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin glulisine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Medical University of Graz. Started Mar 2017; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2017-000955-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000955-25.